nach oben

Calcified Tissue International

Erschienen in:

01.08.2003 | Controversies and Coutnerpoints

Inflammatory Mediators as Essential Elements in Bone Remodeling

verfasst von: S. R. Goldring

Erschienen in: Calcified Tissue International | Ausgabe 2/2003

Einloggen, um Zugang zu erhalten

Abstract

Inflammatory disorders such as rheumatoid arthritis (RA), may have profound effects on skeletal homeostasis. In contrast to physiologic remodeling in which mechanical influences and/or systemic endocrine hormones initiate the remodeling process, in disorders such as RA the recruitment of macrophage lineage cells to sites of inflammation and the action of local osteoclastogenic cytokines associated with the inflammatory process initiate the remodeling process. In both physiologic and pathologic remodeling, osteoclasts appear to be the principal cell type responsible for the bone resorption. In addition, many of the same cytokines and mediators are involved in physiologic and pathologic bone remodeling. These observations have important implications with respect to the development of therapeutic strategies to prevent bone loss in inflammatory conditions.

Burr, DB 2002Targeted and nontargeted remodeling.Bone3024CrossRefPubMed

Parfitt, AM 2002Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression.Bone3057CrossRefPubMed

Parfitt, A 2001Targeted and non-targeted bone remodeling: relationship to BMU origination and progression.Bone30585587

Martin, RB 2002Is all cortical bone remodeling initiated by microdamage?Bone30813CrossRefPubMed

Hofbauer, LC, Khosla, S, Dunstan, CR, et al. 2000The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.J Bone Miner Res15212PubMed

Suda, T, Takahashi, N, Udagawa, N, et al. 1999Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.Endocr Rev20345357PubMed

Teitelbaum, S 2000Bone resorption by osteoclasts.Science28915041508CrossRefPubMed

Goldring, SR, Gravallese, EM 2000Pathogenesis of bone erosions in rheumatoid arthritis.Curr Opin Rheumatol12195199CrossRefPubMed

Simonet, WS, Lacey, DL, Dunstan, CR, et al. 1997Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.Cell89309319PubMed

10.

Romas, E, Gillespie, M, Martin, T 2002Involvement of receptor activator of NF-κβ ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis.Bone30340346CrossRefPubMed

11.

Kanzaki, H, Chiba, M, Shimizu, Y, et al. 2002Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via PGE2 synthesis.J Bone Miner Res17210220PubMed

12.

Bateman, T, Dunstan, C, Ferguson, V, et al. 2000Osteoprotegerin mitigates tail suspension-induced osteopenia.Bone26443449PubMed

13.

Kobayashi, Y, Hashimoto, F, Miyamoto, H, et al. 2000Force-induced osteoclast apoptosis in vivo is accompanied by elevation in transforming growth factor beta and osteoprotegerin expression.J Bone Miner Res1519241934PubMed

14.

Goldring, SR, Gravallese, EM 2000Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications.Arthritis Res23337CrossRefPubMed

15.

Gravallese, EM, Manning, C, Tsay, A, et al. 2000Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.Arthritis Rheum43250258PubMed

16.

Haynes, DR, Crotti, TN, Loric, M, et al. 2001Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint.Rheumatology (Oxford)40623630CrossRef

17.

Kuratani, T, Nagata, K, Kukita, T, et al. 1998Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover.Histol Histopathol13751759PubMed

18.

Romas, E, Bakharevski, O, Hards, DK, et al. 2000Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis.Arthritis Rheum43821826PubMed

19.

Suzuki, Y, Nishikaku, F, Nakatuka, M, et al. 1998Osteoclast-like cells in murine collagen-induced arthritis.J Rheumatol2511541160PubMed

20.

Fujikawa, Y, Shingu, M, Torisu, T, et al. 1996Bone resorption by tartrate-resistant acid phosphatase-positive multinuclear cells isolated from rheumatoid synovium.Br J Rheumatol35213217PubMed

21.

Chang, JS, Quinn, JM, Demaziere, A, et al. 1992Bone resorption by cells isolated from rheumatoid synovium.Ann Rheum Dis512231229

22.

Suzuki, Y, Tsutsumi, Y, Nakagawa, M, et al. 2001Osteoclast-like cells in an in vitro model of bone destruction by rheumatoid synovium.Rheumatology (Oxford)40673682CrossRef

23.

Pettit, A, Hong, J, von Stechow, D, et al. 2001TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis.Am J Pathol15916891699PubMed

24.

Redlich, K, Hayer, S, Maier, A, et al. 2002Tumor necrosis factor-α-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.Arthritis Rheum46785792CrossRefPubMed

25.

Kong, YY, Feige, U, Sarosi, I, et al. 1999Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.Nature402304309PubMed

26.

Horwood, NJ, Kartsogiannis, V, Quinn, JMW, et al. 1999Activated T lymphocytes support osteoclast formation in vitro.Biochem Biophys Res Commun265144150CrossRefPubMed

27.

Takayanagi, H, Iizuka, H, Juji, T, et al. 2000Involvement of receptor activator of nuclear factor kappa-β ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.Arthritis Rheum43259269PubMed

28.

Tsuboi, M, Kawakami, A, Nakashima, T, et al. 1999Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts.J Lab Clin Med134190191PubMed

29.

Chen, S, Guttridge, D, Tang, E, et al. 2001Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor kappaβ-independent bone morphogenetic protein/Smad signaling.J Biol Chem2763925939263CrossRefPubMed

30.

Shimizu, S, Shiozawa, S, Shiozawa, K, et al. 1985Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis.Arthritis Rheum282531PubMed

31.

Bromley, M, Woolley, DE 1984Histopathology of the rheumatoid lesion: identification of cell types at sites of cartilage erosion.Arthritis Rheum27857863PubMed

32.

Goldring, SR 1996Osteoporosis and rheumatic diseases.Favus, MJ eds. Primer on the metabolic bone diseases and disorders of mineral metabolism, 3rd ed.Lippincott-RavenPhiladelphia299301

33.

Goldring, SR, Polisson, RP 1998Bone disease in rheumatological disorders.Avioli, LKrane, SM eds. Metabolic bone disease, 2nd ed.Academic PressSan Diego621635

34.

Saag, K, Rochelle, K, Caldwell, J, et al. 1994Low-dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events.Am J Med96115123PubMed

Titel: Inflammatory Mediators as Essential Elements in Bone Remodeling
verfasst von: S. R. Goldring
Publikationsdatum: 01.08.2003
Verlag: Springer-Verlag
Erschienen in: Calcified Tissue International / Ausgabe 2/2003
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI: https://doi.org/10.1007/s00223-002-1049-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2003

bFGF Administration Lowers the Phosphate Threshold for Mineralization in Bone Marrow Stromal Cells

Fatigue Microdamage as an Essential Element of Bone Mechanics and Biology

Increase in Tartrate-Resistant Acid Phosphatase of Bone at the Early Stage of Ascorbic Acid Deficiency in the Ascorbate-Requiring Osteogenic Disorder Shionogi (ODS) Rat

Mineralization of Basement Membrane Mediates Dentogingival Adhesion in Mammalian and Nonmammalian Vertebrates

Pattern of Periprosthetic Bone Remodeling Around Stable Uncemented Tapered Hip Stems: A prospective 84-month follow-up study and a Median 156-month Cross-Sectional Study with DXA